ClinicalTrials.Veeva

Menu

Comprehensive Assessment of Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis

Z

Ziv Hospital

Status

Unknown

Conditions

Atherosclerosis, Coronary
Cardiovascular Diseases
Rheumatoid Arthritis

Study type

Observational

Funder types

Other

Identifiers

NCT03813017
0123-18-ZIV

Details and patient eligibility

About

Cardiovascular disease is a leading cause for morbidity and mortality in general population. The incidence of cardiovascular disease and their poor outcome is well documented in a broad spectrum of connective tissue diseases, especially in rheumatoid arthritis (RA). The risk of incident CVD is increased by 48% in patients with RA compared to the general population.

RA is associated with 50% increase in the mortality in patients with cardiovascular disease (CVD). One reason is the more frequent cardiovascular risk factors in RA patients compared with the general population. Patients with RA have a high risk of premature cardiovascular disease (CVD). The aim of the present study is to assess whether there are non-invasive measures that might predict arteriosclerosis in RA patients.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 18-70 years old (except for women till 75 years old)

  2. Absence of established CVD:

    • Myocardial Infarction p/h
    • PCI with balloon and/or stent
    • Intermittent claudication
    • PAD / intervention
    • CAS /intervention
  3. Signed informed consent form

  4. Documented diagnosis of rheumatoid arthritis

Exclusion criteria

  1. Known CVD
  2. Pregnancy

Trial contacts and locations

0

Loading...

Central trial contact

Karine Beiruti, PhD; Naaem Simaan, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems